-
IBB Dashboard
- Holdings
iShares Biotechnology ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 554.12 mm | 6.00 mm shares | 8.57 | Common equity | Long | USA |
AMGN Amgen Inc. | 511.74 mm | 1.96 mm shares | 7.92 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 492.56 mm | 691.48 k shares | 7.62 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 477.76 mm | 1.19 mm shares | 7.39 | Common equity | Long | USA |
BlackRock Cash Funds: Institutional, SL Agency Shares | 465.81 mm | 465.58 mm shares | 7.21 | Short-term investment vehicle | Long | USA |
IQV IQVIA Holdings Inc. | 230.88 mm | 1.17 mm shares | 3.57 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 196.50 mm | 835.06 k shares | 3.04 | Common equity | Long | USA |
Argenx SE
|
188.09 mm | 305.83 k shares | 2.91 | Common equity | Long | Netherlands |
MTD Mettler-Toledo International Inc. | 165.96 mm | 135.62 k shares | 2.57 | Common equity | Long | USA |
BIIB Biogen Inc. | 144.41 mm | 944.32 k shares | 2.23 | Common equity | Long | USA |
WAT Waters Corporation | 143.66 mm | 387.25 k shares | 2.22 | Common equity | Long | USA |
BNTX BioNTech SE | 138.98 mm | 1.22 mm shares | 2.15 | Common equity | Long | Germany |
ILMN Illumina, Inc. | 137.27 mm | 1.03 mm shares | 2.12 | Common equity | Long | USA |
NTRA Natera, Inc. | 128.12 mm | 809.35 k shares | 1.98 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 100.91 mm | 286.00 k shares | 1.56 | Common equity | Long | USA |
MRNA Moderna, Inc. | 93.13 mm | 2.24 mm shares | 1.44 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 91.03 mm | 492.83 k shares | 1.41 | Common equity | Long | Cayman Islands |
NBIX Neurocrine Biosciences, Inc. | 87.79 mm | 643.12 k shares | 1.36 | Common equity | Long | USA |
INCY Incyte Corporation | 85.45 mm | 1.24 mm shares | 1.32 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 80.74 mm | 1.23 mm shares | 1.25 | Common equity | Long | USA |
INSM Insmed Incorporated | 78.60 mm | 1.14 mm shares | 1.22 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 73.92 mm | 1.03 mm shares | 1.14 | Common equity | Long | USA |
Genmab A/S
|
70.93 mm | 3.40 mm shares | 1.10 | Common equity | Long | Denmark |
SRPT Sarepta Therapeutics, Inc. | 70.57 mm | 580.39 k shares | 1.09 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 64.22 mm | 784.54 k shares | 0.99 | Common equity | Long | USA |
CRL Charles River Laboratories International, Inc. | 60.96 mm | 330.21 k shares | 0.94 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 60.52 mm | 1.82 mm shares | 0.94 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 55.31 mm | 166.49 k shares | 0.86 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 54.01 mm | 646.72 k shares | 0.84 | Common equity | Long | USA |
RGEN Repligen Corporation | 48.95 mm | 340.05 k shares | 0.76 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 42.24 mm | 306.82 k shares | 0.65 | Common equity | Long | Denmark |
RVMD Revolution Medicines, Inc. | 40.26 mm | 920.37 k shares | 0.62 | Common equity | Long | USA |
BRKR Bruker Corporation | 39.38 mm | 671.85 k shares | 0.61 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 39.27 mm | 821.47 k shares | 0.61 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 37.02 mm | 119.96 k shares | 0.57 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 35.09 mm | 402.28 k shares | 0.54 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 34.88 mm | 741.48 k shares | 0.54 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 33.21 mm | 950.06 k shares | 0.51 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 30.56 mm | 939.05 k shares | 0.47 | Common equity | Long | Cayman Islands |
Alkermes plc
|
29.81 mm | 1.04 mm shares | 0.46 | Common equity | Long | Ireland |
Roivant Sciences Ltd.
|
29.14 mm | 2.46 mm shares | 0.45 | Common equity | Long | Bermuda |
CRNX Crinetics Pharmaceuticals, Inc. | 28.95 mm | 566.12 k shares | 0.45 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 26.44 mm | 963.61 k shares | 0.41 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 25.59 mm | 1.49 mm shares | 0.40 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 24.88 mm | 158.81 k shares | 0.38 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 22.90 mm | 544.24 k shares | 0.35 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 21.98 mm | 486.84 k shares | 0.34 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 21.85 mm | 258.28 k shares | 0.34 | Common equity | Long | USA |
Biohaven Ltd.
|
21.63 mm | 579.08 k shares | 0.33 | Common equity | Long | Virgin Islands (British) |
NUVL Nuvalent, Inc. | 21.21 mm | 270.90 k shares | 0.33 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 21.16 mm | 663.01 k shares | 0.33 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
20.94 mm | 532.13 k shares | 0.32 | Common equity | Long | Switzerland |
RNA Avidity Biosciences, Inc. | 20.58 mm | 707.62 k shares | 0.32 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 20.40 mm | 266.04 k shares | 0.32 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 19.76 mm | 498.90 k shares | 0.31 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 19.71 mm | 1.07 mm shares | 0.30 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 19.63 mm | 350.60 k shares | 0.30 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 19.50 mm | 451.23 k shares | 0.30 | Common equity | Long | USA |
Novocure Ltd.
|
18.96 mm | 636.36 k shares | 0.29 | Common equity | Long | Jersey |
XENE Xenon Pharmaceuticals Inc. | 18.78 mm | 479.11 k shares | 0.29 | Common equity | Long | Canada |
FOLD Amicus Therapeutics, Inc. | 17.94 mm | 1.90 mm shares | 0.28 | Common equity | Long | USA |
VCEL Vericel Corporation | 17.56 mm | 319.78 k shares | 0.27 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 17.11 mm | 368.29 k shares | 0.26 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 16.57 mm | 813.11 k shares | 0.26 | Common equity | Long | USA |
VRNA Verona Pharma plc | 16.39 mm | 352.82 k shares | 0.25 | Common equity | Long | UK |
Merus NV
|
16.05 mm | 381.69 k shares | 0.25 | Common equity | Long | Netherlands |
SWTX SpringWorks Therapeutics, Inc. | 15.49 mm | 428.65 k shares | 0.24 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 14.88 mm | 277.98 k shares | 0.23 | Common equity | Long | USA |
Zai Lab Ltd.
|
14.55 mm | 555.62 k shares | 0.23 | Common equity | Long | Cayman Islands |
KYMR Kymera Therapeutics, Inc. | 14.38 mm | 357.39 k shares | 0.22 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 14.23 mm | 756.70 k shares | 0.22 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 14.16 mm | 366.78 k shares | 0.22 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 13.55 mm | 320.32 k shares | 0.21 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 13.32 mm | 1.97 mm shares | 0.21 | Common equity | Long | USA |
GERN Geron Corporation | 13.02 mm | 3.68 mm shares | 0.20 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 12.93 mm | 503.06 k shares | 0.20 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 12.04 mm | 674.65 k shares | 0.19 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 11.91 mm | 1.61 mm shares | 0.18 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 11.82 mm | 501.67 k shares | 0.18 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 11.81 mm | 213.34 k shares | 0.18 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 11.80 mm | 359.22 k shares | 0.18 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 11.74 mm | 473.44 k shares | 0.18 | Common equity | Long | USA |
MESO Mesoblast Limited | 11.65 mm | 588.51 k shares | 0.18 | Common equity | Long | Australia |
MNKD MannKind Corporation | 11.20 mm | 1.74 mm shares | 0.17 | Common equity | Long | USA |
Tempus AI, Inc.
|
10.99 mm | 325.47 k shares | 0.17 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 10.89 mm | 852.92 k shares | 0.17 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 10.86 mm | 406.64 k shares | 0.17 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 10.81 mm | 579.88 k shares | 0.17 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 10.77 mm | 237.80 k shares | 0.17 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 10.65 mm | 382.97 k shares | 0.16 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 10.36 mm | 250.49 k shares | 0.16 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 10.09 mm | 407.46 k shares | 0.16 | Common equity | Long | USA |
XNCR Xencor, Inc. | 9.92 mm | 431.83 k shares | 0.15 | Common equity | Long | USA |
GRFS Grifols, S.A. | 9.91 mm | 1.33 mm shares | 0.15 | Common equity | Long | Spain |
TVTX Travere Therapeutics, Inc. | 9.73 mm | 558.47 k shares | 0.15 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
9.58 mm | 774.60 k shares | 0.15 | Common equity | Long | Singapore |
Alvotech SA
|
9.41 mm | 711.06 k shares | 0.15 | Common equity | Long | Luxembourg |
TXG 10x Genomics, Inc. | 9.40 mm | 654.40 k shares | 0.15 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 9.34 mm | 670.68 k shares | 0.14 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 9.26 mm | 1.23 mm shares | 0.14 | Common equity | Long | USA |
GLPG Galapagos NV | 9.09 mm | 330.62 k shares | 0.14 | Common equity | Long | Belgium |
PRAX Praxis Precision Medicines, Inc. | 8.64 mm | 112.26 k shares | 0.13 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 8.46 mm | 448.87 k shares | 0.13 | Common equity | Long | USA |
NVAX Novavax, Inc. | 8.02 mm | 996.98 k shares | 0.12 | Common equity | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 7.87 mm | 7.87 mm shares | 0.12 | Short-term investment vehicle | Long | USA |
MYGN Myriad Genetics, Inc. | 7.83 mm | 570.81 k shares | 0.12 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 7.70 mm | 268.35 k shares | 0.12 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 7.66 mm | 457.38 k shares | 0.12 | Common equity | Long | UK |
NTLA Intellia Therapeutics, Inc. | 7.60 mm | 652.18 k shares | 0.12 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 7.53 mm | 277.77 k shares | 0.12 | Common equity | Long | Cayman Islands |
AUPH Aurinia Pharmaceuticals Inc. | 7.53 mm | 838.27 k shares | 0.12 | Common equity | Long | Canada |
ARVN Arvinas, Inc. | 7.43 mm | 387.78 k shares | 0.12 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 7.38 mm | 317.20 k shares | 0.11 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 7.36 mm | 249.49 k shares | 0.11 | Common equity | Long | UK |
Newamsterdam Pharma Co. NV
|
7.19 mm | 279.61 k shares | 0.11 | Common equity | Long | Netherlands |
Stevanato Group SpA
|
7.02 mm | 322.35 k shares | 0.11 | Common equity | Long | Italy |
CDNA CareDx, Inc | 7.00 mm | 326.79 k shares | 0.11 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 6.98 mm | 528.15 k shares | 0.11 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 6.80 mm | 540.88 k shares | 0.11 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 6.45 mm | 101.78 k shares | 0.10 | Common equity | Long | USA |
Zymeworks Inc. | 6.40 mm | 437.13 k shares | 0.10 | Common equity | Long | USA |
EVO Evotec SE | 5.92 mm | 1.42 mm shares | 0.09 | Common equity | Long | Germany |
AVXL Anavex Life Sciences Corp. | 5.74 mm | 534.92 k shares | 0.09 | Common equity | Long | USA |
ETNB 89bio, Inc. | 5.73 mm | 732.46 k shares | 0.09 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 5.65 mm | 445.68 k shares | 0.09 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 5.58 mm | 929.95 k shares | 0.09 | Common equity | Long | USA |
CTKB Cytek Biosciences, Inc. | 4.95 mm | 762.50 k shares | 0.08 | Common equity | Long | USA |
uniQure NV
|
4.91 mm | 278.03 k shares | 0.08 | Common equity | Long | Netherlands |
CSTL Castle Biosciences, Inc. | 4.76 mm | 178.50 k shares | 0.07 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 4.73 mm | 390.55 k shares | 0.07 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 4.67 mm | 313.45 k shares | 0.07 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 4.61 mm | 350.22 k shares | 0.07 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 4.52 mm | 579.39 k shares | 0.07 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 4.50 mm | 1.01 mm shares | 0.07 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 4.46 mm | 198.00 k shares | 0.07 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc. | 4.24 mm | 1.45 mm shares | 0.07 | Common equity | Long | Canada |
PSTX Poseida Therapeutics, Inc. | 4.21 mm | 438.36 k shares | 0.07 | Common equity | Long | USA |
LENZ LENZ Therapeutics, Inc. | 4.21 mm | 145.72 k shares | 0.07 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 4.18 mm | 568.84 k shares | 0.06 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings, Inc. | 4.17 mm | 765.80 k shares | 0.06 | Common equity | Long | USA |
LAB Standard BioTools Inc. | 4.11 mm | 2.35 mm shares | 0.06 | Common equity | Long | USA |
Prothena Corp. plc
|
4.04 mm | 291.84 k shares | 0.06 | Common equity | Long | Ireland |
NUVB Nuvation Bio Inc. | 3.95 mm | 1.49 mm shares | 0.06 | Common equity | Long | USA |
ORKA Oruka Therapeutics Inc. | 3.80 mm | 196.19 k shares | 0.06 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 3.75 mm | 353.97 k shares | 0.06 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 3.70 mm | 425.10 k shares | 0.06 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 3.53 mm | 334.44 k shares | 0.05 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 3.41 mm | 675.70 k shares | 0.05 | Common equity | Long | USA |
ArriVent Biopharma, Inc.
|
3.38 mm | 126.72 k shares | 0.05 | Common equity | Long | USA |
ALT Altimmune, Inc. | 3.31 mm | 459.55 k shares | 0.05 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 3.31 mm | 185.16 k shares | 0.05 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 3.27 mm | 794.38 k shares | 0.05 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 3.24 mm | 231.64 k shares | 0.05 | Common equity | Long | UK |
EBS Emergent BioSolutions Inc. | 3.24 mm | 338.94 k shares | 0.05 | Common equity | Long | USA |
CRMD CorMedix Inc. | 3.15 mm | 389.37 k shares | 0.05 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 3.14 mm | 959.22 k shares | 0.05 | Common equity | Long | Canada |
NxStage Medical, Inc. | 3.13 mm | 1.71 mm shares | 0.05 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 3.12 mm | 196.80 k shares | 0.05 | Common equity | Long | USA |
OPK OPKO Health, Inc. | 3.05 mm | 2.07 mm shares | 0.05 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 3.01 mm | 208.67 k shares | 0.05 | Common equity | Long | USA |
ANNX Annexon, Inc. | 2.99 mm | 582.00 k shares | 0.05 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 2.96 mm | 267.96 k shares | 0.05 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 2.94 mm | 241.44 k shares | 0.05 | Common equity | Long | USA |
ZVRA Zevra Therapeutics, Inc. | 2.88 mm | 345.78 k shares | 0.04 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 2.85 mm | 1.21 mm shares | 0.04 | Common equity | Long | UK |
ATXS Astria Therapeutics, Inc. | 2.81 mm | 314.40 k shares | 0.04 | Common equity | Long | USA |
Theravance Biopharma, Inc.
|
2.78 mm | 295.25 k shares | 0.04 | Common equity | Long | Cayman Islands |
Arcturus Therapeutics Holdings, Inc. | 2.72 mm | 160.13 k shares | 0.04 | Common equity | Long | USA |
ERAS Erasca, Inc. | 2.67 mm | 1.06 mm shares | 0.04 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 2.66 mm | 1.04 mm shares | 0.04 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 2.64 mm | 634.18 k shares | 0.04 | Common equity | Long | USA |
TYRA Tyra Biosciences, Inc. | 2.56 mm | 184.53 k shares | 0.04 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
2.53 mm | 237.92 k shares | 0.04 | Common equity | Long | Israel |
QTRX Quanterix Corporation | 2.48 mm | 233.55 k shares | 0.04 | Common equity | Long | USA |
CDXS Codexis, Inc. | 2.45 mm | 513.79 k shares | 0.04 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 2.44 mm | 141.32 k shares | 0.04 | Common equity | Long | USA |
FLGT Fulgent Genetics, Inc. | 2.40 mm | 129.77 k shares | 0.04 | Common equity | Long | USA |
TECX Tectonic Therapeutic Inc | 2.34 mm | 50.72 k shares | 0.04 | Common equity | Long | USA |
SPOT Spotify Technology S.A. | 2.32 mm | 236.61 k shares | 0.04 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 2.32 mm | 411.08 k shares | 0.04 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 2.30 mm | 279.33 k shares | 0.04 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 2.26 mm | 292.15 k shares | 0.03 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 2.25 mm | 406.00 k shares | 0.03 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 2.24 mm | 169.25 k shares | 0.03 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 2.22 mm | 274.53 k shares | 0.03 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 2.09 mm | 300.89 k shares | 0.03 | Common equity | Long | USA |
MeiraGTx Holdings plc
|
2.08 mm | 342.32 k shares | 0.03 | Common equity | Long | Cayman Islands |
CureVac NV
|
2.08 mm | 610.06 k shares | 0.03 | Common equity | Long | Netherlands |
RAPP Rapport Therapeutics, Inc. Common Stock | 2.02 mm | 113.85 k shares | 0.03 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 2.00 mm | 938.40 k shares | 0.03 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 1.99 mm | 97.98 k shares | 0.03 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 1.94 mm | 357.27 k shares | 0.03 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 1.90 mm | 154.21 k shares | 0.03 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 1.90 mm | 242.23 k shares | 0.03 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 1.90 mm | 623.53 k shares | 0.03 | Common equity | Long | USA |
RIGL Rigel Pharmaceuticals, Inc. | 1.89 mm | 112.49 k shares | 0.03 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 1.88 mm | 323.02 k shares | 0.03 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 1.88 mm | 231.38 k shares | 0.03 | Common equity | Long | USA |
KalVista Pharmaceuticals, Inc.
|
1.78 mm | 210.67 k shares | 0.03 | Common equity | Long | USA |
SVRA Savara Inc. | 1.75 mm | 569.93 k shares | 0.03 | Common equity | Long | USA |